ICCC · Immucell Corp
United States · RS rating 81 · As of 2026-11-03
| Price | 10.25 USD |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 72 / 56 / 89 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 60 / 43 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +167.7% |
| Sales growth Q/Q | +38.5% |
| Distance from 52-week high | +12.5% |
| Market cap (USD) | $72.4M |